Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05810051

Exercise and Coronary Microvascular Disease

Effects of a Cardiac Rehabilitation Program on Health-related Quality of Life in Patients With Coronary Microvascular Disease.

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
204 (estimated)
Sponsor
CoreAalst BV · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Exercise CMD is a prospective single-center, open-label, parallel arms randomized controlled trial. This trial aims to assess the impact of cardiac rehabilitation on top of optimal medical therapy on patient-reported outcomes in subjects with coronary microvascular disease and non-obstructive coronary artery disease. Patients will undergo a microvascular assessment using bolus thermodilution techniques and those with criteria for microvascular angina (IMR ≥ 25) will be invited to participate. Patients will be randomized in a 1:1 ratio to either optimal medical therapy (OMT) or OMT plus a program of cardiac rehabilitations (CR). After randomization, spiro-ergometry and a SAQ-19 will be performed in all patients. Medical therapy will be standardized in both arms and the CR group will follow 36 sessions of the personalized physical training program of cardiac rehabilitation. Approximately 204 subjects (102 in each group) will be included at one site (OLV Aalst, Belgium). Clinical Follow-Up will be planned at 4 months. Patients with CCTA performed in standard of care will be invited for control CCTA 6 +/- 1 month after the invasive procedure.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCardiac rehabilitationThe patients in this arm will be trained for 1 hour, 2 or 3 times per week for 36 sessions. In addition to the training program, the patients also get access to the cardiovascular educational program. The training (a 1h session) consists of 60% cardiovascular endurance training and 40% resistance training.

Timeline

Start date
2023-07-31
Primary completion
2026-04-15
Completion
2027-10-15
First posted
2023-04-12
Last updated
2026-01-20

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT05810051. Inclusion in this directory is not an endorsement.